Total Payments
$15,344
2024 Payments
$5,130
Companies
55
Transactions
702
Medicare Patients
716
Medicare Billing
$54,750
Payment Breakdown by Category
Food & Beverage$15,213 (99.1%)
Education$131.98 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,213 | 697 | 99.1% |
| Education | $131.98 | 5 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,091 | 104 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,348 | 53 | $0 (2024) |
| Novo Nordisk Inc | $1,114 | 65 | $0 (2024) |
| Lilly USA, LLC | $973.95 | 42 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $906.49 | 50 | $0 (2024) |
| PFIZER INC. | $712.16 | 37 | $0 (2024) |
| Axsome Therapeutics, Inc. | $674.53 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $658.40 | 21 | $0 (2024) |
| Amgen Inc. | $575.59 | 25 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $530.25 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,130 | 198 | ABBVIE INC. ($557.07) |
| 2023 | $4,036 | 180 | ABBVIE INC. ($873.87) |
| 2022 | $3,283 | 169 | AstraZeneca Pharmaceuticals LP ($477.09) |
| 2021 | $2,895 | 155 | AstraZeneca Pharmaceuticals LP ($427.65) |
All Payment Transactions
702 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/17/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $43.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: GENETIC DISEASE | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Endocrinology | ||||||
| 12/09/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: OUD | ||||||
| 12/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: CNS | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.62 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/25/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/21/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: OUD | ||||||
| 11/21/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Obesity | ||||||
| 11/21/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $9.99 | General |
| Category: Narcoplepsy | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $109.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: PAIN | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.45 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/12/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $15.79 | General |
| Category: Narcoplepsy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 372 | 517 | $82,678 | $27,096 |
| 2022 | 9 | 264 | 592 | $62,664 | $23,139 |
| 2021 | 1 | 22 | 23 | $4,924 | $1,695 |
| 2020 | 3 | 58 | 73 | $11,235 | $2,819 |
Total Patients
716
Total Services
1,205
Medicare Billing
$54,750
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 251 | $53,734 | $16,673 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 40 | 40 | $8,850 | $3,890 | 44.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 16 | $7,400 | $2,570 | 34.7% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 14 | 14 | $4,550 | $1,957 | 43.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 66 | 66 | $3,362 | $903.54 | 26.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 56 | 63 | $945.00 | $529.20 | 56.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 19 | 27 | $2,700 | $333.45 | 12.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 24 | $816.00 | $185.68 | 22.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 16 | $320.00 | $54.56 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 186 | $39,819 | $14,253 | 35.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 35 | 35 | $7,752 | $3,583 | 46.2% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 15 | 18 | $5,850 | $2,530 | 43.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 16 | 16 | $5,410 | $2,112 | 39.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 27 | 27 | $1,172 | $326.18 | 27.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 36 | 45 | $675.00 | $132.69 | 19.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 13 | $442.00 | $115.62 | 26.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 15 | 19 | $380.00 | $65.10 | 17.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 20 | 233 | $1,165 | $21.57 | 1.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 23 | $4,924 | $1,695 | 34.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 49 | $10,490 | $2,642 | 25.2% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 11 | 11 | $550.00 | $138.34 | 25.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 11 | 13 | $195.00 | $38.46 | 19.7% |
About Laronda Lang, ARNP
Laronda Lang, ARNP is a Family healthcare provider based in Clearwater, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2017. The National Provider Identifier (NPI) number assigned to this provider is 1154850683.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Laronda Lang, ARNP has received a total of $15,344 in payments from pharmaceutical and medical device companies, with $5,130 received in 2024. These payments were reported across 702 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($15,213).
As a Medicare-enrolled provider, Lang has provided services to 716 Medicare beneficiaries, totaling 1,205 services with total Medicare billing of $54,750. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Clearwater, FL
- Active Since 06/08/2017
- Last Updated 06/08/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1154850683
Products in Payments
- VRAYLAR (Drug) $972.08
- NURTEC ODT (Drug) $641.21
- Auvelity (Drug) $616.64
- MOUNJARO (Drug) $611.56
- Ozempic (Drug) $584.89
- QULIPTA (Drug) $525.13
- FARXIGA (Drug) $522.14
- UBRELVY (Drug) $518.86
- ABILIFY MAINTENA (Drug) $509.65
- JARDIANCE (Drug) $504.36
- XIFAXAN (Drug) $456.82
- ARISTADA (Drug) $445.03
- REXULTI (Drug) $399.21
- AIRSUPRA (Drug) $333.46
- Korlym (Drug) $328.26
- VOQUEZNA (Drug) $321.13
- EVENITY (Biological) $314.42
- WAKIX (Drug) $291.52
- Austedo XR (Drug) $288.39
- SUBLOCADE (Drug) $270.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Clearwater
Ms. Marian Finehirsh, Aprn-C, APRN-C
Family — Payments: $25,723
Family $25,723
Mrs. Jaime Burns, Aprn, APRN
Family — Payments: $12,519
Family $12,519
Ms. Karen Duclon, Arnp, ARNP
Family — Payments: $11,414
Family $11,414
Mrs. Amanda Browne, Aprn Fnp-C, APRN FNP-C
Family — Payments: $10,258
Family $10,258
Shreya Patel, Aprn, APRN
Family — Payments: $7,214
Family $7,214
Cara Palermo, Aprn, APRN
Family — Payments: $6,172
Family $6,172